CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $858.28M, above the global median of $520.53M
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
530.86MUSDvs all stocks (USD)
Revenue (TTM)
858.28MUSDvs all stocks (USD)
Profit Margin
-156.66%Beta
1.90xvs all stocks
52-Week Change
-35.82%vs all stocks
Market Capitalization
530.86MUSDvs all stocks (USD)
Enterprise Value
1.84BUSDvs all stocks (USD)
Forward P/E
16.79xPrice to Sales (TTM)
0.6185xPrice to Book (MRQ)
1.42xEnterprise to Revenue
2.15xEnterprise to EBITDA
103.72xGross Margin
26.58%Profit Margin
-156.66%Operating Margin
-52.70%Return on Assets (TTM)
-1.47%Return on Equity (TTM)
-63.16%Revenue (TTM)
858.28MUSDvs all stocks (USD)
Revenue per Share (TTM)
8.04USDUpdated Jul 19, 2026Quarterly Revenue Growth
-7.80%Gross Profit (TTM)
237.55MUSDvs all stocks (USD)
EBITDA (TTM)
19.43MUSDvs all stocks (USD)
Net Income (TTM)
-1.34BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
11.28%Operating Cash Flow (TTM)
-44.63MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-31.06MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
-21.90MUSDFY2025 · May 31, 2025Revenue
821.31MUSDFY2025 · May 31, 2025Cost of Goods Sold
580.74MUSDFY2025 · May 31, 2025Gross Profit
240.57MUSDFY2025 · May 31, 2025Operating Income
-107.81MUSDvs all stocks (USD)
Pre-tax Income
-2.30BUSDFY2025 · May 31, 2025Income Tax Expense
-121.02MUSDFY2025 · May 31, 2025Net Income
-2.18BUSDFY2025 · May 31, 2025EBIT
-2.26BUSDFY2025 · May 31, 2025EBITDA (Income Statement)
19.43MUSDFY2025 · May 31, 2025Research & Development
284.00KUSDFY2025 · May 31, 2025Selling, General & Administrative
259.48MUSDFY2025 · May 31, 2025Non-operating Interest Income
11.38MUSDFY2025 · May 31, 2025Non-operating Interest Expense
41.33MUSDFY2025 · May 31, 2025EPS (Basic)
-24.60USDFY2025 · May 31, 2025EPS (Diluted)
-24.60USDFY2025 · May 31, 2025Basic Shares Outstanding
89.03MSharesFY2025 · May 31, 2025Diluted Shares Outstanding
89.03MSharesFY2025 · May 31, 2025Net Income from Continuing Operations
-2.18BUSDFY2025 · May 31, 2025Minority Interests (P&L)
-5.38MUSDFY2025 · May 31, 2025Operating Cash Flow
-2.15BUSDFY2025 · May 31, 2025Free Cash Flow
-2.17BUSDFY2025 · May 31, 2025Cash & Cash Equivalents (End of Period)
221.67MUSDFY2025 · May 31, 2025Starting Profit (CF Statement)
-2.18BUSDFY2025 · May 31, 2025Depreciation & Amortization
133.49MUSDFY2025 · May 31, 2025Deferred Taxes (CF)
-121.02MUSDFY2025 · May 31, 2025Stock-based Compensation
24.29MUSDFY2025 · May 31, 2025Other Non-cash Items
30.32MUSDFY2025 · May 31, 2025Change in Accounts Receivable (CF)
-17.80MUSDFY2025 · May 31, 2025Change in Other Assets/Liabilities
-13.56MUSDFY2025 · May 31, 2025Capital Expenditures
-26.09MUSDFY2025 · May 31, 2025Net Acquisitions
-18.11MUSDFY2025 · May 31, 2025Net Investing Cash Flow
-44.20MUSDFY2025 · May 31, 2025Long-term Debt Issuance
3.45MUSDFY2025 · May 31, 2025Long-term Debt Payments
-18.74MUSDFY2025 · May 31, 2025Net Short-term Debt Issuance
-10.85MUSDFY2025 · May 31, 2025Common Stock Repurchase
0.00USDFY2025 · May 31, 2025Other Financing Charges
-1.54MUSDFY2025 · May 31, 2025Net Financing Cash Flow
133.51MUSDFY2025 · May 31, 2025Shares Outstanding
116.23MSharesUpdated Jul 19, 2026Shares Short
17.80MSharesUpdated Jul 19, 2026Short Ratio
4.90daysvs all stocks
Short % of Shares Outstanding
14.52%vs all stocks
% Held by Insiders
0.71%vs all stocks
% Held by Institutions
9.38%vs all stocks
Total Cash (MRQ)
425.66MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9510USDUpdated Jul 19, 2026Total Debt (MRQ)
343.90MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.6361xCurrent Ratio (MRQ)
2.79xBook Value per Share (MRQ)
3.02USDUpdated Jul 19, 2026Total Assets
2.07BUSDvs all stocks (USD)
Total Current Assets
688.63MUSDFY2025 · May 31, 2025Total Liabilities
584.75MUSDFY2025 · May 31, 2025Total Non-current Assets
1.39BUSDFY2025 · May 31, 2025Total Non-current Liabilities
304.45MUSDFY2025 · May 31, 2025Total Current Liabilities
280.30MUSDFY2025 · May 31, 2025Cash & Cash Equivalents
221.67MUSDFY2025 · May 31, 2025Other Short-term Investments
34.70MUSDFY2025 · May 31, 2025Accounts Receivable
121.49MUSDFY2025 · May 31, 2025Inventory
270.88MUSDFY2025 · May 31, 2025Accounts Payable
107.35MUSDFY2025 · May 31, 2025Short-term Debt
28.89MUSDFY2025 · May 31, 2025Other Current Liabilities
16.09MUSDFY2025 · May 31, 2025Long-term Debt
299.85MUSDFY2025 · May 31, 2025Other Non-current Liabilities
855.00KUSDFY2025 · May 31, 2025Common Stock (Book)
106.00KUSDFY2025 · May 31, 2025Retained Earnings
-4.85BUSDFY2025 · May 31, 2025Total Shareholders' Equity
1.49BUSDvs all stocks (USD)
Treasury Stock
0.00USDFY2025 · May 31, 202552-Week Low
4.20USDUpdated Jul 19, 202652-Week High
23.20USDUpdated Jul 19, 202652-Week Change
-35.82%vs all stocks
Beta
1.90xvs all stocks
50-Day MA
4.97USDUpdated Jul 19, 2026200-Day MA
8.41USDUpdated Jul 19, 2026Avg 10-Day Volume
3.48MSharesUpdated Jul 19, 2026Avg 30-Day Volume
3.71MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-14.63USDUpdated Jul 19, 2026Other Income / Expense
-2.16BUSDFY2025 · May 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $858.28M, above the global median of $520.53MNotable
Revenue (USD): 858,275,008Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Bioperfectus Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Shanghai General Healthy Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
TaiMed Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shandong Wohua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Morepen Laboratories Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Nanjing Well Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Daewoong Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Huaren Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Tasuki Holdings Inc.
1 interpretationOperating Income Growing With Multi-Year Revenue Growth
Hebei Sinopack Electronic Co., Ltd.
1 interpretationOperating Income Growing With Multi-Year Revenue Growth
Çimsa Çimento Sanayi ve Ticaret A.Ş.
1 interpretationOperating Income Growing With Multi-Year Revenue Growth